Regencell Bioscience Holdings Ltd (RGC): Total Liabilities

Annual figures by period end, from SEC filings.

$1.38M
As of 2026-06-30
+29.7%
3-year compound annual growth
-20.5%
5-year compound annual growth
$4.34M2020-06-30: $3.16M2021-06-30: $4.34M2022-06-30: $938.0K2023-06-30: $632.3K2024-06-30: $219.5K2025-06-30: $895.3K2026-06-30: $1.38M$1.38M
2020-06-30 Total Liabilities (USD) 2026-06-30
Period endedTotal LiabilitiesChange YoYSource filing
2026-06-30$1.38M+54.2%2026-10-07, Balance as of period end
2025-06-30$895.3K+307.9%2026-10-07, Balance as of period end
2024-06-30$219.5K-65.3%2025-10-31, Balance as of period end
2023-06-30$632.3K-32.6%2024-10-25, Balance as of period end
2022-06-30$938.0K-78.4%2023-10-27, Balance as of period end
2021-06-30$4.34M+37.1%2022-10-31, Balance as of period end
2020-06-30$3.16Mn/a2021-10-29, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Regencell Bioscience Holdings Ltd (RGC)2026-06-30$1.38M+54.2%
Charlie's Holdings, Inc. (CHUC)2025-12-31$8.14M+42.2%
Cyanotech Corp (CYAN)2025-03-31$14.61M+9.8%
Functional Brands Inc. (MEHA)2025-12-31$7.57M+3.8%
Healthy Extracts Inc. (HYEX)2025-12-31$3.80M+92.9%
Mannatech Inc (MTEX)2025-12-31$35.22M+28.3%
Target Group Inc. (CBDY)2025-12-31$14.24M+1.1%
Leef Brands Inc. (LEEEF)2025-12-31$44.67M-19.4%
TFA Therapeutics, Inc. (RAJAF)2025-12-31$5.19M+3.9%

Compare RGC, CHUC, CYAN, MEHA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗